×

Nucleoside phosphoramidate prodrugs

  • US 8,735,372 B2
  • Filed: 10/18/2013
  • Issued: 05/27/2014
  • Est. Priority Date: 03/30/2007
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a human infected by hepatitis C virus, comprising administering to the subject an effective amount of an NS5a inhibitor and an effective amount of a compound represented by the following formula:

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×